Øystein Rekdal

4.6k total citations
68 papers, 3.0k citations indexed

About

Øystein Rekdal is a scholar working on Molecular Biology, Microbiology and Immunology. According to data from OpenAlex, Øystein Rekdal has authored 68 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 34 papers in Microbiology and 28 papers in Immunology. Recurrent topics in Øystein Rekdal's work include Antimicrobial Peptides and Activities (34 papers), RNA Interference and Gene Delivery (23 papers) and Immunotherapy and Immune Responses (22 papers). Øystein Rekdal is often cited by papers focused on Antimicrobial Peptides and Activities (34 papers), RNA Interference and Gene Delivery (23 papers) and Immunotherapy and Immune Responses (22 papers). Øystein Rekdal collaborates with scholars based in Norway, France and Sweden. Øystein Rekdal's co-authors include John S. Svendsen, Morten B. Strøm, Baldur Sveinbjørnsson, Bengt Erik Haug, Ketil André Camilio, Wenche Stensen, Gerd Marit Berge, Liv Tone Eliassen, Nannan Yang and Lars Uhlin‐Hansen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Øystein Rekdal

67 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Øystein Rekdal Norway	34	1.9k	1.6k	870	394	298	68	3.0k
Adam Lesner Poland	26	1.1k 0.6×	264 0.2×	553 0.6×	337 0.9×	80 0.3×	125	2.1k
Xurui Cheng China	7	1.3k 0.7×	658 0.4×	191 0.2×	151 0.4×	40 0.1×	9	2.0k
Diana Gaspar Portugal	20	1.5k 0.8×	1.0k 0.6×	235 0.3×	125 0.3×	30 0.1×	32	2.0k
Mare Čudić United States	26	1.2k 0.6×	385 0.2×	622 0.7×	316 0.8×	31 0.1×	73	2.1k
M. Victòria Nogués Spain	33	1.7k 0.9×	1.5k 0.9×	606 0.7×	160 0.4×	20 0.1×	70	2.7k
Linghua Zhang China	25	890 0.5×	148 0.1×	354 0.4×	255 0.6×	141 0.5×	89	2.3k
Adam Dubin Poland	28	1.1k 0.6×	337 0.2×	484 0.6×	297 0.8×	56 0.2×	97	2.2k
R J DeLange United States	25	1.9k 1.0×	394 0.2×	270 0.3×	198 0.5×	69 0.2×	34	3.0k
B. Dunbar United Kingdom	24	1.3k 0.7×	299 0.2×	365 0.4×	74 0.2×	146 0.5×	46	2.1k
Chean Eng Ooi United States	19	1.4k 0.7×	417 0.3×	672 0.8×	269 0.7×	215 0.7×	31	2.4k

Countries citing papers authored by Øystein Rekdal

Since Specialization

Citations

This map shows the geographic impact of Øystein Rekdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Øystein Rekdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Øystein Rekdal more than expected).

Fields of papers citing papers by Øystein Rekdal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Øystein Rekdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Øystein Rekdal. The network helps show where Øystein Rekdal may publish in the future.

Co-authorship network of co-authors of Øystein Rekdal

This figure shows the co-authorship network connecting the top 25 collaborators of Øystein Rekdal. A scholar is included among the top collaborators of Øystein Rekdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Øystein Rekdal. Øystein Rekdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xiaoqing, Takahiro Yamazaki, Jia Liu, et al.. (2024). LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells. Frontiers in Immunology. 15. 1332922–1332922. 6 indexed citations

Dalle, Stéphane, Thomas U. Marron, Caroline Robert, et al.. (2023). 1051P Intratumoral injection of LTX-315 in combination with pembrolizumab in patients with advanced melanoma refractory to prior PD-1/PD-L1 therapy: Interim results from the ATLAS-IT-05 trial. Annals of Oncology. 34. S636–S636. 4 indexed citations

Fleten, Karianne G., Ketil André Camilio, Terje Vasskog, et al.. (2021). Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer. Scientific Reports. 11(1). 6731–6731. 7 indexed citations

Camilio, Ketil André, Mengyu Wang, Gunnar Kvalheim, et al.. (2019). Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model. Breast Cancer Research. 21(1). 9–9. 52 indexed citations

Zhou, Heng, Laura Mondragón, Wei Xie, et al.. (2018). Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals. Cell Death and Disease. 9(11). 1086–1086. 17 indexed citations

Zhou, Heng, Sabrina Forveille, Allan Sauvat, et al.. (2016). The oncolytic peptide LTX-315 triggers immunogenic cell death. Cell Death and Disease. 7(3). e2134–e2134. 99 indexed citations

Camilio, Ketil André, Gerd Marit Berge, Chandra Sekhar Ravuri, Øystein Rekdal, & Baldur Sveinbjørnsson. (2014). Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315. Cancer Immunology Immunotherapy. 63(6). 601–613. 74 indexed citations

Uhlin‐Hansen, Lars, et al.. (2011). Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells. BMC Cancer. 11(1). 116–116. 41 indexed citations

Rekdal, Øystein, Bengt Erik Haug, Howard N. Hunter, et al.. (2011). Relative Spatial Positions of Tryptophan and Cationic Residues in Helical Membrane-active Peptides Determine Their Cytotoxicity. Journal of Biological Chemistry. 287(1). 233–244. 48 indexed citations

10.

Berge, Gerd Marit, Liv Tone Eliassen, Ketil André Camilio, et al.. (2010). Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide. Cancer Immunology Immunotherapy. 59(8). 1285–1294. 59 indexed citations

11.

Rekdal, Øystein, et al.. (2009). The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells. BMC Cancer. 9(1). 183–183. 50 indexed citations

12.

Stensvåg, Klara, Tor Haug, Sigmund Sperstad, et al.. (2007). Arasin 1, a proline–arginine-rich antimicrobial peptide isolated from the spider crab, Hyas araneus. Developmental & Comparative Immunology. 32(3). 275–285. 96 indexed citations

13.

Eliassen, Liv Tone, Gerd Marit Berge, Cecilie Løkke, et al.. (2006). The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo. International Journal of Cancer. 119(3). 493–500. 158 indexed citations

14.

Jenssen, Håvard, Tore Jarl Gutteberg, Øystein Rekdal, & Tore Lejon. (2006). Prediction of Activity, Synthesis and Biological Testing of anti‐HSV Active Peptides. Chemical Biology & Drug Design. 68(1). 58–66. 11 indexed citations

15.

Yang, Nannan, et al.. (2003). The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells. Journal of Peptide Science. 10(1). 37–46. 62 indexed citations

16.

Jenssen, Håvard, Jeanette H. Andersen, Lars Uhlin‐Hansen, Tore Jarl Gutteberg, & Øystein Rekdal. (2003). Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antiviral Research. 61(2). 101–109. 86 indexed citations

17.

Yang, Nannan, Tore Lejon, & Øystein Rekdal. (2003). Antitumour activity and specificity as a function of substitutions in the lipophilic sector of helical lactoferrin‐derived peptide. Journal of Peptide Science. 9(5). 300–311. 43 indexed citations

18.

Strøm, Morten B., Øystein Rekdal, & John S. Svendsen. (2001). The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin. Journal of Peptide Science. 8(1). 36–43. 42 indexed citations

19.

Rekdal, Øystein, et al.. (1996). Evidence for Exclusive Role of the p55 Tumor Necrosis Factor (TNF) Receptor in Mediating the TNF-Induced Collagenase Expression by Human Dermal Fibroblasts. Journal of Investigative Dermatology. 107(4). 565–568. 7 indexed citations

20.

Bartnes, Kristian, Øystein Rekdal, Jean‐Paul Briand, & Kristian Hannestad. (1993). Th1 clones that suppress IgG2a^b specifically recognize an allopeptide determinant comprising residues 435–451 of γ2a^b. European Journal of Immunology. 23(10). 2655–2660. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact